The efficacy of a two-dose hepatitis B vaccination scheme

Advances in Experimental Medicine and Biology

Volumn 531, Issue , 2003, Pages 185-190

  Boland, Greet J ^a   Van Bommel, Toon ^a   Van Den Berg, Annemarie Rulos ^b   Van Den Berg, Jan P B ^c   Van Loon, Anton M ^a   Van Hattum, Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Budi Kemuliaan Hospital   (Indonesia)

^c Netherlands Batam Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; HEPATITIS B; HUMAN; INCIDENCE; INFECTION PREVENTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VACCINATION; VIRUS TRANSMISSION;

EID: 0041883764     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0059-9_14     Document Type: Conference Paper

References (7)

1. Ahn Y.O., 1996, Strategy for vaccination against hepatitis B in areas with high endemicity: focus on Korea, Gut 38 (suppl 2): S63-66.
2. Andre F., 2000, Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine, 18 (suppl 1): S20-22.
3. Chen, C.J., Wang, L.Y., Yu, M.W.,2000, Epidemiology of hepatitis B virus infection in the Asian-Pacific region, J. Gastroenterol. Hepatol 15 (suppl. E): S3-6.
4. Gust I.D., 1996, Immunisation against hepatitis B in Taiwan, Gut 38 (suppl 2): S67-68.
5. Lansang M.A.D., 1996, Epidemiology and control of hepatitis B infection: aperspective from the Phillipines, Asia, Gut 38 (suppl 2): S43-47.
6. Yao G.B., 1996, Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China, Gut 38 (suppl 2): S41-48.
7. Yao J.L., 1996, Perinatal transmission of hepatits B virus infection and vaccinationin China. Gut 38 (suppl 2): S37-38.